No one likes to hear the word cancer – we know that. But if you do hear it, you want to feel comfortable knowing you're getting the best care available. We're here for you.
At University of Iowa Holden Comprehensive Cancer Center, our highly experienced physicians and staff are dedicated to taking care of you, not just your cancer. As part of a nationally recognized cancer center, our team focuses on every aspect of neuroendocrine cancer – our clinicians are also top researchers, finding new and innovative treatments and therapies, as well as identifying genetic links that may pinpoint risk. We are on the leading edge of neuroendocrine research, always searching for ways to make the best cancer treatment even better.
Holden Comprehensive Cancer Center is the only institution in Iowa to hold the prestigious designation of being a Comprehensive Cancer Center by the National Cancer Institute (NCI). What that means for you is that we are recognized among the leading cancer centers in the United States; NCI-designated Comprehensive Cancer Centers are rated in the top 4 percent of the approximately 1,500 cancer centers in the United States. A recent study published in the journal Cancer showed that patients treated at NCI designated cancer centers have better survival outcomes than patients treated at non-NCI designated cancer centers.
To be considered a “comprehensive” center means our teams have expertise in clinical, laboratory and population-based research. Our doctors and staff are on top of the newest developments in cancer research, treatment and diagnosis.
That means our team of experts will design a treatment plan that is tailored to your individual needs – we don’t believe in "one size fits all."
Our multidisciplinary team is ready to offer all of the services you need for your neuroendocrine care. We know no one wants to stay in the hospital longer than necessary, so we work especially hard to make sure your treatment options are done on an out-patient basis, allowing you to rest in the comfort of your own home.
We bring experts from different fields of medicine to work together as a team called a multidisciplinary oncology group. Because many neuroendocrine patients require more than one form of treatment, our team meets regularly to discuss the best course of treatment and works together to design the best personalized plan for every patient. The team includes Surgical Oncologists, Endocrine Oncologists, Medical Oncologists, Radiation Oncologists, Social Workers, Pathologists, Pediatric Oncologists, Pharmacists, Nurses, and laboratory-based Scientists. Our team of specialists focuses not just on neuroendocrine cancer, but on your neuroendocrine cancer.
Researchers at the University of Iowa Holden Comprehensive Cancer Center have received a five-year, $10.67 million Specialized Programs of Research Excellence (SPORE) grant to study neuroendocrine tumors. This is the first and only SPORE grant ever awarded to fund research on neuroendocrine tumors.
Clinical trials is where research meets patient care. A great deal of research is done behind the scenes in laboratories, long before clinical trials can even begin. Clinical trials are research studies that test out the latest treatments and drugs that are not yet available to the wider public. These new treatments have the potential to improve your quality of life or increase your chances of survival.
See a full list and learn more about neuroendocrine cancer clinical trials at Holden Comprehensive Cancer Center.
Our work is made possible in part by the support of donors through charitable giving. Friends of Holden Comprehensive Cancer Center can become partners in the effort to control and ultimately cure cancer. Learn how you can help us make a difference for cancer patients.